Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShort-Term Debt repayments
Ratios

Conmed (CNMD) Accumulated Depreciation & Amortization (2016 - 2025)

Conmed (CNMD) has disclosed Accumulated Depreciation & Amortization for 15 consecutive years, with $305.4 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Accumulated Depreciation & Amortization rose 4.54% year-over-year to $305.4 million, compared with a TTM value of $305.4 million through Dec 2024, up 4.54%, and an annual FY2024 reading of $305.4 million, up 4.54% over the prior year.
  • Accumulated Depreciation & Amortization was $305.4 million for Q4 2024 at Conmed, up from $292.2 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $305.4 million in Q4 2024 and bottomed at $246.0 million in Q4 2020.
  • Average Accumulated Depreciation & Amortization over 5 years is $277.0 million, with a median of $277.5 million recorded in 2022.
  • The sharpest move saw Accumulated Depreciation & Amortization increased 7.94% in 2020, then rose 4.54% in 2024.
  • Year by year, Accumulated Depreciation & Amortization stood at $246.0 million in 2020, then grew by 7.22% to $263.8 million in 2021, then grew by 5.22% to $277.5 million in 2022, then rose by 5.27% to $292.2 million in 2023, then rose by 4.54% to $305.4 million in 2024.
  • Business Quant data shows Accumulated Depreciation & Amortization for CNMD at $305.4 million in Q4 2024, $292.2 million in Q4 2023, and $277.5 million in Q4 2022.